Advanced search×

Biomaterials advances in patches for congenital heart defect repair.

J Cardiovasc Transl Res 4(5):646-54 (2011) PMID 21647794

This article reviews current applications and novel candidate biomaterials for use as tissue-engineered scaffolds in pediatric cardiac tissue engineering. This overview of different types of biomaterials includes naturally derived and synthetic polymers and their biological, physical, and biomechanical properties for the use as a patch or baffle for surgical reconstruction of congenital heart defects. Applications and characteristics of composite biomaterials are highlighted with their respective feasibilities in use as cardiac scaffolds. Currently, a wide range of biomaterials has been introduced for cardiovascular reconstruction for complex congenital cardiac defects. However, there are still many remaining challenges for engineered tissue implantations.

DOI: 10.1007/s12265-011-9289-8
Version: za2963e q8za7 q8zba q8zc7 q8zd9 q8zee q8zf2 q8zg8

Similar articles you may find interesting…

  1. Human percutaneous absorption of a direct hair dye comparing in vitro and in vivo results: Implications for safety assessment and animal tes...

    Food Chem Toxicol 46(6):10 (2008) PMID 18417263

    We studied the dermal absorption of a hair dye hydroxyanthraquinone-aminopropyl methyl morpholinium methosulphate (HAM) in human skin in vivo and in vitro. In vivo, skin (back and scalp) received 0.5% HAM in a commercial formulation at 20microg/cm2 After 0.5 or 48h, skin was tape stripped, followed...
  2. Stem cell factor expression after renal ischemia promotes tubular epithelial survival.

    Audio, Transactions of the IRE Profession... 5(12):e14386 (2010) PMID 21200435

    We studied how expression of c-KIT on tubular epithelium and its ligand SCF protect cells against apoptosis. Administration of SCF specific antisense oligonucleotides significantly decreased specific staining of SCF following ischemia. Reduced SCF expression resulted in impaired renal function, incr...
  3. Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and ...

    Stem Cell Res Ther 2(4):31 (2011) PMID 21745421

    We have found that when muscle-derived stem cells (MDSCs) are implanted into a variety of tissues only a small fraction of the donor cells can be found within the regenerated tissues and the vast majority of cells are host derived. This observation has also been documented by other investigators usi...